You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

 

Online download statistics by month:

Online download statistics by month: September 2022 to August 2025

AbstractFullPdf
Sep 2022504535238
Oct 2022430436163
Nov 202221222889
Dec 202221222068
Jan 202314714856
Feb 202319119485
Mar 202315215265
Apr 202318619051
May 202312612749
Jun 202318619371
Jul 202313213251
Aug 202312713059
Sep 2023879133
Oct 2023959647
Nov 202311911954
Dec 202315415572
Jan 202415615884
Feb 2024929252
Mar 202412912972
Apr 202415015164
May 2024144147169
Jun 202411811765
Jul 202415115765
Aug 202410110152
Sep 2024949545
Oct 202411511645
Nov 2024878852
Dec 202412413252
Jan 202515115473
Feb 202512712957
Mar 202522122589
Apr 202514414551
May 202510711045
Jun 202510210547
Jul 2025110
Aug 2025110
Total537554992430